Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionThe Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis.Structural Elements Recognized by Abacavir-Induced T Cells.A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys.Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms.HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infectionGenetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicityHLA Association with Drug-Induced Adverse Reactions.Rare disease prevention and treatment: the need for a level playing field.Distinct HLA associations of LGI1 and CASPR2-antibody diseases.A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents
P2860
Q24273350-645B6B52-B5DF-45EB-A47D-667437114A1AQ36208161-D6ED0F8C-CCA8-4489-B034-F0AFED31D29EQ38263760-74100FEF-670C-445E-AE27-FD6950A062F9Q38689568-FB5D3319-3ACD-4DBA-9C38-B6F059A7EBD8Q38777644-0F4ECFF2-5C9E-4BE8-B755-5616455B78DCQ39159544-002385F2-8C34-49E0-AC1E-1016D7F9D9DCQ39179349-FC2C642C-D1BE-4EEB-ADED-26AC30624AE6Q39291741-CC49E65A-E8D1-46F4-95A1-3DEAA293DF4EQ40112223-8299E60D-45AF-4265-8EC6-60B493C29AACQ40373921-1147E001-E803-40FE-B794-2B62D0400AD0Q40502992-67319924-159F-43E5-B2F4-0E7BF0F0EB6CQ41389082-A6015AB0-20C9-407D-A230-FBCC0434F26AQ42072504-CD703594-51F0-4EF8-B0E0-82187909E7F2Q42362078-51F4A7D6-FB53-4F33-A847-1CDEFB157728Q47553722-8D3EDE0C-9EA6-4CE7-B895-2116770BB7ACQ50071892-C48EE8A9-BBE8-4E22-A9DB-D6BD62AA15F4Q55457015-E1F4B62D-0E36-4B3C-95F7-67C677FE5D9FQ58787671-821B99F2-7702-4D6B-911F-94E82904760C
P2860
Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
@en
type
label
Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
@en
prefLabel
Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
@en
P2860
P1476
Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
@en
P2093
A Alfirevic
P2860
P2888
P304
P356
10.1007/S12016-014-8418-Y
P577
2015-06-01T00:00:00Z
P5875
P6179
1017587936